Brean Murray Carret & Co Key Takeaways From Mindray Medical International (MR)

Brean Murray Carret & Co were impressed by Mindray Medical International, Ltd MR smooth integration of Datascope. It believes successful collaboration between MR's US and China R&D teams combined with the right pricing strategy will drive MR's long term global expansion. Brean Murray Carret & Co reported that MR's China tender business growth started to pick up in 3Q and management believes for 2010, as local governments slowly invest in the medical device area, total tender sales will still be only half of that of 2009. Brean Murray Carret & Co rates MR as a HOLD. Learn how to find the best stocks to trade each day in our 70 page E-Book and 90 minute online video for free.